216 related articles for article (PubMed ID: 28602711)
1. Patients' perceptions and attitudes on recurrent prostate cancer and hormone therapy: Qualitative comparison between decision-aid and control groups.
Gorawara-Bhat R; O'Muircheartaigh S; Mohile S; Dale W
J Geriatr Oncol; 2017 Sep; 8(5):368-373. PubMed ID: 28602711
[TBL] [Abstract][Full Text] [Related]
2. Early salvage hormonal therapy for biochemical failure improved survival in prostate cancer patients after neoadjuvant hormonal therapy plus radiation therapy--a secondary analysis of irish clinical oncology research group 97-01.
Mydin AR; Dunne MT; Finn MA; Armstrong JG
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):101-8. PubMed ID: 22658512
[TBL] [Abstract][Full Text] [Related]
3. Decision-making Processes among Prostate Cancer Survivors with Rising PSA Levels: Results from a Qualitative Analysis.
Shen MJ; Nelson CJ; Peters E; Slovin SF; Hall SJ; Hall M; Herrera PC; Leventhal EA; Leventhal H; Diefenbach MA
Med Decis Making; 2015 May; 35(4):477-86. PubMed ID: 25385751
[TBL] [Abstract][Full Text] [Related]
4. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
[TBL] [Abstract][Full Text] [Related]
5. Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator.
van Vugt HA; Roobol MJ; Venderbos LD; Joosten-van Zwanenburg E; Essink-Bot ML; Steyerberg EW; Bangma CH; Korfage IJ
Eur J Cancer; 2010 Feb; 46(3):669-77. PubMed ID: 20022239
[TBL] [Abstract][Full Text] [Related]
6. Impact of a web-based prostate cancer treatment decision aid on patient-reported decision process parameters: results from the Prostate Cancer Patient Centered Care trial.
Cuypers M; Lamers RED; Kil PJM; van de Poll-Franse LV; de Vries M
Support Care Cancer; 2018 Nov; 26(11):3739-3748. PubMed ID: 29752528
[TBL] [Abstract][Full Text] [Related]
7. Impact of a decision aid on newly diagnosed prostate cancer patients' understanding of the rationale for active surveillance.
Formica MK; Wason S; Seigne JD; Stewart TM
Patient Educ Couns; 2017 May; 100(5):812-817. PubMed ID: 27923674
[TBL] [Abstract][Full Text] [Related]
8. A decision aid versus shared decision making for prostate cancer screening: results of a randomized, controlled trial.
Stamm AW; Banerji JS; Wolff EM; Slee A; Akapame S; Dahl K; Massman I I I JD; Soung MC; Pittenger KR; Corman JM
Can J Urol; 2017 Aug; 24(4):8910-8917. PubMed ID: 28832310
[TBL] [Abstract][Full Text] [Related]
9. Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy.
Moul JW; Wu H; Sun L; McLeod DG; Amling C; Donahue T; Kusuda L; Sexton W; O'Reilly K; Hernandez J; Chung A; Soderdahl D
J Urol; 2004 Mar; 171(3):1141-7. PubMed ID: 14767288
[TBL] [Abstract][Full Text] [Related]
10. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
O'Dell KJ; Volk RJ; Cass AR; Spann SJ
J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
[TBL] [Abstract][Full Text] [Related]
11. The language of prostate cancer treatments and implications for informed decision making by patients.
Rot I; Ogah I; Wassersug RJ
Eur J Cancer Care (Engl); 2012 Nov; 21(6):766-75. PubMed ID: 22574619
[TBL] [Abstract][Full Text] [Related]
12. "The booklet helped me not to panic": a pilot of a decision aid for asymptomatic women with ovarian cancer and with rising CA-125 levels.
Anderson C; Carter J; Nattress K; Beale P; Philp S; Harrison J; Juraskova I
Int J Gynecol Cancer; 2011 May; 21(4):737-43. PubMed ID: 21412158
[TBL] [Abstract][Full Text] [Related]
13. Impact of a web-based treatment decision aid for early-stage prostate cancer on shared decision-making and health outcomes: study protocol for a randomized controlled trial.
Cuypers M; Lamers RE; Kil PJ; van de Poll-Franse LV; de Vries M
Trials; 2015 May; 16():231. PubMed ID: 26012700
[TBL] [Abstract][Full Text] [Related]
14. Influence of a patient decision aid on decisional conflict related to PSA testing: a structural equation model.
Stephens RL; Xu Y; Volk RJ; Scholl LE; Kamin SL; Holden EW; Stroud LA
Health Psychol; 2008 Nov; 27(6):711-721. PubMed ID: 19025266
[TBL] [Abstract][Full Text] [Related]
15. Rising PSA in nonmetastatic prostate cancer.
Moul JW; Bañez LL; Freedland SJ
Oncology (Williston Park); 2007 Nov; 21(12):1436-45; discussion 1449, 1452, 1454. PubMed ID: 18077992
[TBL] [Abstract][Full Text] [Related]
16. Methodology of patient care for elevated PSA after prostate cancer treatment: A primary care perspective.
Baum N; Levy J
Postgrad Med; 2015 Aug; 127(6):654-9. PubMed ID: 26118565
[TBL] [Abstract][Full Text] [Related]
17. [Local recurrence of prostate cancer: hormone therapy].
Altwein JE; Ebert T
Urologe A; 2006 Oct; 45(10):1276, 1278-82. PubMed ID: 16998661
[TBL] [Abstract][Full Text] [Related]
18. Informed decision making before prostate-specific antigen screening: Initial results using the American Cancer Society (ACS) Decision Aid (DA) among medically underserved men.
Gökce MI; Wang X; Frost J; Roberson P; Volk RJ; Brooks D; Canfield SE; Pettaway CA
Cancer; 2017 Feb; 123(4):583-591. PubMed ID: 27727462
[TBL] [Abstract][Full Text] [Related]
19. Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy.
Valentini AL; Gui B; D'Agostino GR; Mattiucci G; Clementi V; Di Molfetta IV; Bonomo P; Mantini G
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):719-24. PubMed ID: 22436789
[TBL] [Abstract][Full Text] [Related]
20. The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD.
Pacyna JE; Kim S; Yost K; Sedlacek H; Petereit D; Kaur J; Rapkin B; Grubb R; Paskett E; Chang GJ; Sloan J; Basch E; Major B; Novotny P; Taylor J; Buckner J; Parsons JK; Morris M; Tilburt JC
BMC Cancer; 2018 Aug; 18(1):788. PubMed ID: 30081846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
